Research on transforming growth factor-β in the repair process of skin burn patients

被引:0
|
作者
Li, Dan [1 ]
Wang, Jinhuang [1 ]
Jiang, Xuan [1 ]
Chen, Guangping [1 ]
Yang, Xiao [1 ]
Liu, Dalie [1 ]
机构
[1] Southern Med Univ, Zhujiang Hosp, Dept Burn & Plast Surg, 253 Gongye Ave, Guangzhou 510280, Guangdong, Peoples R China
关键词
Transforming growth factor-beta; skin burn; C-reactive protein; chitosan wound repair; WOUNDS; MANAGEMENT; DRESSINGS;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: To investigate transforming growth factor-beta (TGF-beta) in the repair process of skin burn patients. Methods: A total of 164 burn patients treated in Zhujiang Hospital, Southern Medical University from September 2014 to December 2016 were enrolled as objects of study, and were divided into: control group (n=82, including 37 cases of second-degree superficial burns and 45 cases of second-degree deep burns) and an observation group (n=82, including 42 cases of second-degree superficial burns and 40 cases of second-degree deep burns), using a random number table. Patients in the control group were treated with wound dressing by using single-layer Vaseline gauze, while those in the observation group were treated with external application of chitosan wound repair membrane gel. Tetanus antitoxin was intramuscularly injected into patients in both groups to prevent tetanus, and antibiotics were used to prevent bacterial infection. Wound healing, healing time, and wound healing scar index (SI) were observed and compared between the two groups at 7, 15, and 25 days after treatment, and the expression level of TGF-beta in the peripheral blood was detected via enzyme-linked immunosorbent assay before treatment and at 15 and 25 days after treatment, respectively. Results: Comparison of wound healing between the control group and the observation group revealed that the healing rate of patients with second-degree superficial burns in the observation group treated with chitosan at 7 days after treatment increased compared with that of patients with second-degree superficial burns in the control group, with a statistically significant difference (P<0.05). The healing rates of patients with second-degree deep burns in both groups at 15 and 25 days after treatment also increased significantly, with a statistically significant difference between the two groups (P<0.05). The healing time of patients with second-degree superficial burns in the observation group was obviously shorter than that of patients with second-degree superficial burns in the control group, displaying a statistically significant difference between the two groups (P<0.05), and the SI score of patients in the observation group treated with chitosan was obviously lower than that in the control group (P<0.05). Moreover, the healing time of patients with second-degree deep burns in the observation group was also shorter than that in the control group, showing a statistically significant difference between the two groups (P<0.05). The SI score of patients in the observation group treated with chitosan was also obviously lower than that in the control group (P<0.05). According to the comparison of TGF-beta expression before treatment and at 15 and 25 days after treatment between the two groups of patients, expression levels of TGF-beta in both groups were decreased gradually at 15 days with a difference between the two groups (P<0.05), but no significant difference was found in the expression level of TGF-beta at 25 days between the two groups (P>0.05). Conclusion: External application of chitosan wound repair membrane gel significantly shortens the recovery time of patients, and it is expected that TGF-beta expression level can serve as one of the evaluation indexes for patient recovery.
引用
收藏
页码:9662 / 9669
页数:8
相关论文
共 50 条
  • [21] Transforming growth factor-β1 and splenocyte apoptotic cell death after burn injuries
    Nishimura, T
    Nishiura, T
    deSerres, S
    Nakagawa, T
    Meyer, AA
    JOURNAL OF BURN CARE & REHABILITATION, 2000, 21 (02): : 128 - 134
  • [22] Healing of burn wounds in transgenic mice overexpressing transforming growth factor-β1 in the epidermis
    Yang, LJ
    Chan, T
    Demare, J
    Iwashina, T
    Ghahary, A
    Scott, PG
    Tredget, EE
    AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (06): : 2147 - 2157
  • [23] Expression of transforming growth factor-β1 and transforming growth factor-β receptors in hepatocellular carcinoma and dysplastic nodules
    Paik, SY
    Park, YN
    Kim, H
    Park, C
    MODERN PATHOLOGY, 2003, 16 (01) : 86 - 96
  • [24] Dynamic expression patterns of transforming growth factor-β2 and transforming growth factor-β receptors in experimental glomerulonephritis
    Andrea Hartner
    Karl F. Hilgers
    Markus Bitzer
    Roland Veelken
    Harald O. Schöcklmann
    Journal of Molecular Medicine, 2003, 81 : 32 - 42
  • [25] Dynamic expression patterns of transforming growth factor-β2 and transforming growth factor-β receptors in experimental glomerulonephritis
    Hartner, A
    Hilgers, KF
    Bitzer, M
    Veelken, R
    Schöcklmann, HO
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2003, 81 (01): : 32 - 42
  • [26] Active transforming growth factor-β in wound repair -: Determination using a new assay
    Yang, LJ
    Qiu, CX
    Ludlow, A
    Ferguson, MWJ
    Brunner, G
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (01): : 105 - 111
  • [27] Transforming growth factor-β3 promotes facial nerve injury repair in rabbits
    Wang, Yanmei
    Zhao, Xinxiang
    Huojia, Muhter
    Xu, Hui
    Zhuang, Youmei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (03) : 703 - 708
  • [28] The immunity modulation of transforming growth factor-β in malaria and other pathological process
    Wu, Shuang
    Nie, Qing
    Tan, Shuang
    Liao, Guoyan
    Lv, Yinyi
    Lv, Caohua
    Chen, Guang
    Liu, Shuangchun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 122
  • [29] Detection of transforming growth factor-α in the serum of gastric carcinoma patients
    Choi, JH
    Kim, HC
    Lim, HY
    Nam, DK
    Kim, HS
    Yi, SY
    Shim, KS
    Han, WS
    ONCOLOGY, 1999, 57 (03) : 236 - 241
  • [30] Anti-transforming growth factor-β therapy in patients with myelofibrosis
    Mascarenhas, John
    Li, Timmy
    Sandy, Lonette
    Newsom, Carrie
    Petersen, Bruce
    Godbold, James
    Hoffman, Ronald
    LEUKEMIA & LYMPHOMA, 2014, 55 (02) : 450 - 452